Recombinant human epidermal growth factor α2b gel has not been identified as harmful, it has the effect of making wounds healing. Recombinant human epidermal growth factor α2b gel can promote wound healing when applied externally, and is used for the treatment of skin burn wounds (superficial II degree to deep II degree burn wounds), residual wounds, skin donor area wounds and chronic ulcer wounds. No serious adverse reactions have been observed. Recombinant human epidermal growth factor α2b gel should be contraindicated in those who are hypersensitive to it. Although the use of this product is usually harmless, it should be used in moderation. It should be discontinued after the wound has healed to prevent adverse reactions. Patients are advised to go to the hospital to consult the doctor in detail and standardize the use of medication under the doctor’s guidance, do not use it on your own.